(EMR) Emerson Electric - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2910111044
EMR EPS (Earnings per Share)
EMR Revenue
EMR: Valves, Actuators, Measurement, Automation, Tools, Control Systems, Software
Emerson Electric Co. is a global technology and software conglomerate that delivers a diverse array of innovative solutions across multiple regions, including the Americas, Asia, the Middle East, Africa, and Europe. The company operates through seven distinct business segments, each catering to specific industrial needs: Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, Test & Measurement, and AspenTech.
The companys broad portfolio includes critical products and services such as control valves, intelligent instrumentation, automation solutions, professional tools, control systems, and asset optimization software. These offerings enable industrial manufacturers to enhance operational efficiency, safety, and productivity. For instance, Emersons Measurement & Analytical segment provides cutting-edge instrumentation that measures various physical properties, while its Control Systems & Software segment delivers comprehensive control systems and cybersecurity solutions.
With a rich history dating back to 1890, Emerson Electric has established itself as a leader in the electrical components and equipment industry. The companys commitment to innovation and customer satisfaction has enabled it to maintain a strong presence in the global market. As a testament to its financial health, Emerson boasts a significant market capitalization and a respectable return on equity.
Analyzing the
To capitalize on potential opportunities, investors may consider monitoring EMRs future earnings releases, industry trends, and macroeconomic factors that could impact the companys performance. A thorough analysis of the companys financial statements, management guidance, and industry outlook will be crucial in making informed investment decisions.
Additional Sources for EMR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
EMR Stock Overview
Market Cap in USD | 72,371m |
Sector | Industrials |
Industry | Specialty Industrial Machinery |
GiC Sub-Industry | Electrical Components & Equipment |
IPO / Inception | 1972-06-01 |
EMR Stock Ratings
Growth Rating | 72.8 |
Fundamental | 6.68 |
Dividend Rating | 55.7 |
Rel. Strength | 1.8 |
Analysts | 4.27 of 5 |
Fair Price Momentum | 130.89 USD |
Fair Price DCF | 46.27 USD |
EMR Dividends
Dividend Yield 12m | 1.73% |
Yield on Cost 5y | 3.93% |
Annual Growth 5y | 0.95% |
Payout Consistency | 100.0% |
Payout Ratio | 36.5% |
EMR Growth Ratios
Growth Correlation 3m | 84% |
Growth Correlation 12m | 32.8% |
Growth Correlation 5y | 78.9% |
CAGR 5y | 19.50% |
CAGR/Max DD 5y | 0.66 |
Sharpe Ratio 12m | 0.90 |
Alpha | 4.87 |
Beta | 1.407 |
Volatility | 23.05% |
Current Volume | 2723.1k |
Average Volume 20d | 2755.5k |
As of June 25, 2025, the stock is trading at USD 130.73 with a total of 2,723,051 shares traded.
Over the past week, the price has changed by +2.64%, over one month by +8.07%, over three months by +13.81% and over the past year by +21.73%.
Neither. Based on ValueRay´s Fundamental Analyses, Emerson Electric is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 6.68 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EMR is around 130.89 USD . This means that EMR is currently overvalued and has a potential downside of 0.12%.
Emerson Electric has received a consensus analysts rating of 4.27. Therefor, it is recommend to buy EMR.
- Strong Buy: 19
- Buy: 3
- Hold: 6
- Sell: 1
- Strong Sell: 1
According to our own proprietary Forecast Model, EMR Emerson Electric will be worth about 150.7 in June 2026. The stock is currently trading at 130.73. This means that the stock has a potential upside of +15.31%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 135.4 | 3.6% |
Analysts Target Price | 134.4 | 2.8% |
ValueRay Target Price | 150.7 | 15.3% |